This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
A phase 2 trial has linked Blueprint Medicines’ avapritinib to statistically significant...
CRISPR has been all over the news in the past couple of years, and with reason....
SR One fuels HotSpot's $65M B round to fund allosteric R&D ntaylor Thu, 05/21/2020...
Credit: Elena Gialamas Cerri/University of Pittsburgh PITTSBURGH, April 9, 2020...
Credit: Mary Ann Liebert Inc., publishers New Rochelle, NY, April 15, 2020–For optimally...